An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...
Sanofi's experimental drug ataciguat has shown promise in reducing the progression of aortic valve stenosis in clinical trials, potentially delaying the need for surgical valve replacement. With ...
5h
Tribune Content Agency on MSNThe Medicine Cabinet: Ask the Harvard Experts: Why an aortic valve can narrow and impede blood flowQ: My doctor heard a new heart murmur and suspected I have a narrowed valve due to aortic stenosis. I feel fine. Why did this ...
Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...
Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...
Using a small catheter inserted in the leg, the TriClip is delivered to the heart and works by clipping together a portion of the leaflets of the tricuspid valve.
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
Sue Dumbauld got an alert from her Apple Watch that her heart rate was dangerously high. This inspired her to exercise ahead ...
A new drug could manage aortic valve stenosis, slowing disease progression and reducing the need for aortic valve surgeries.
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
Roger Black, who won two Olympic silver medals, has undergone open-heart surgery following a diagnosis of heart-valve disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results